IsoVeil wants radioactive dressing to disappear after doing its job

Field notes

IsoVeil describes a proposed dressing that uses P-32 beta emission to deliver a localized radiation dose to keloids and other fibroproliferative tissue. Its distinctive design brief combines directional shielding with disposal tied to a defined decay window, addressing the site’s stated concern about repeated clinic visits, room-based equipment, and specialized shielding. The homepage offers an email contact for researchers, clinicians, and press, while explicitly stating that the device has not been FDA reviewed or approved and has no demonstrated safety or effectiveness claims here.